Related Experiment Video
Updated: Feb 4, 2026
06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
3.0K
Immunosenescence and lymphomagenesis.
Salvatrice Mancuso1, Melania Carlisi2, Marco Santoro2
11Haematology, Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Immunity & Ageing : I & A
|September 28, 2018
Summary
Immunosenescence, or immune system aging, impacts elderly cancer risk. This review explores its role in Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL), considering Epstein-Barr Virus (EBV) involvement.
Area of Science:
- Immunology
- Oncology
- Gerontology
Background:
- Immunosenescence is a key factor in age-related immune system decline.
- This decline increases susceptibility to infections, cancers, and autoimmune diseases.
- The precise link between immunosenescence and lymphoma in the elderly remains unclear.
Purpose of the Study:
- To review the interplay between aging, cancer, and lymphoma.
- To examine immunosenescence in the context of Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL).
- To explore the role of Epstein-Barr Virus (EBV) in age-related lymphoproliferation.
Main Methods:
- Literature review and synthesis.
- Focus on immunosenescence, aging, cancer, and lymphoma.
- Analysis of EBV's role in lymphomagenesis.
Main Results:
- Immunosenescence contributes to age-related immune dysfunction.
- Epstein-Barr Virus (EBV) is implicated in neoplastic lymphoproliferation.
- The interaction of immune dysfunction, immunosenescence, and EBV differs between NHL and HL subtypes.
Conclusions:
- Immunosenescence significantly influences lymphoma development in the elderly.
- EBV's role in lymphoma pathogenesis is modulated by immune status and aging.
- Further research is needed to clarify these complex interactions for targeted therapies.
